Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 54

1.

Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple-negative breast cancer.

Hu X, Zhang J, Xu B, Jiang Z, Ragaz J, Tong Z, Zhang Q, Wang X, Feng J, Pang D, Fan M, Li J, Wang B, Wang Z, Zhang Q, Sun S, Liao C.

Int J Cancer. 2014 Oct 15;135(8):1961-9. doi: 10.1002/ijc.28829. Epub 2014 Mar 20.

PMID:
24604288
[PubMed - in process]
2.

The SUVmax for (18)F-FDG correlates with molecular subtype and survival of previously untreated metastatic breast cancer.

Zhang J, Jia Z, Zhou M, Ragaz J, Zhang YP, Wang BY, Wang ZH, Hu XC, Zhang YJ.

Clin Nucl Med. 2013 Apr;38(4):256-62. doi: 10.1097/RLU.0b013e3182816318.

PMID:
23429396
[PubMed - indexed for MEDLINE]
3.

The maximum standardized uptake value of 18 F-FDG PET scan to determine prognosis of hormone-receptor positive metastatic breast cancer.

Zhang J, Jia Z, Ragaz J, Zhang YJ, Zhou M, Zhang YP, Li G, Wang BY, Wang ZH, Hu XC.

BMC Cancer. 2013 Jan 31;13:42. doi: 10.1186/1471-2407-13-42.

PMID:
23368410
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Randomized adjuvant trials in oncology: a necessity or time-consuming luxury?

Ragaz J.

Breast Cancer Res. 2010 Dec 20;12 Suppl 4:S14. doi: 10.1186/bcr2743. No abstract available.

PMID:
21172076
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Biomarker alterations with metronomic use of low-dose zoledronic acid for breast cancer patients with bone metastases and potential clinical significance.

Zhao X, Xu X, Guo L, Ragaz J, Guo H, Wu J, Shao Z, Zhu J, Guo X, Chen J, Zhu B, Wang Z, Hu X.

Breast Cancer Res Treat. 2010 Dec;124(3):733-43. doi: 10.1007/s10549-010-1183-6. Epub 2010 Sep 30.

PMID:
20882405
[PubMed - indexed for MEDLINE]
6.

Among women who experience a recurrence after postmastectomy radiation therapy irradiation is not associated with more aggressive local recurrence or reduced survival.

Woodward WA, Truong PT, Yu TK, Tereffe W, Oh J, Perkins G, Strom E, Meric-Bernstam F, Gonzalez-Angulo AM, Speers C, Ragaz J, Buchholz TA.

Breast Cancer Res Treat. 2010 Sep;123(2):597-605. doi: 10.1007/s10549-010-0829-8. Epub 2010 Mar 20.

PMID:
20306128
[PubMed - indexed for MEDLINE]
7.

Radiation impact in breast cancer.

Ragaz J.

Breast Cancer Res. 2009;11 Suppl 3:S14. doi: 10.1186/bcr2433. Epub 2009 Dec 18. Review. No abstract available.

PMID:
20030865
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Adjuvant targeted therapy in early breast cancer.

Mackey J, McLeod D, Ragaz J, Gelmon K, Verma S, Pritchard K, Laing K, Provencher L, Charbonneau LF.

Cancer. 2009 Mar 15;115(6):1154-68. doi: 10.1002/cncr.24114. Review.

PMID:
19165856
[PubMed - indexed for MEDLINE]
Free Article
9.
10.

Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index.

Callagy GM, Pharoah PD, Pinder SE, Hsu FD, Nielsen TO, Ragaz J, Ellis IO, Huntsman D, Caldas C.

Clin Cancer Res. 2006 Apr 15;12(8):2468-75. Erratum in: Clin Cancer Res. 2006 Aug 15;12(16):5002.

PMID:
16638854
[PubMed - indexed for MEDLINE]
Free Article
11.

Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.

Ragaz J, Olivotto IA, Spinelli JJ, Phillips N, Jackson SM, Wilson KS, Knowling MA, Coppin CM, Weir L, Gelmon K, Le N, Durand R, Coldman AJ, Manji M.

J Natl Cancer Inst. 2005 Jan 19;97(2):116-26.

PMID:
15657341
[PubMed - indexed for MEDLINE]
Free Article
12.

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.

Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, Hernandez-Boussard T, Livasy C, Cowan D, Dressler L, Akslen LA, Ragaz J, Gown AM, Gilks CB, van de Rijn M, Perou CM.

Clin Cancer Res. 2004 Aug 15;10(16):5367-74.

PMID:
15328174
[PubMed - indexed for MEDLINE]
Free Article
13.

Therapeutic strategies using the aromatase inhibitor letrozole and tamoxifen in a breast cancer model.

Long BJ, Jelovac D, Handratta V, Thiantanawat A, MacPherson N, Ragaz J, Goloubeva OG, Brodie AM.

J Natl Cancer Inst. 2004 Mar 17;96(6):456-65.

PMID:
15026471
[PubMed - indexed for MEDLINE]
Free Article
14.

Dose density by any other name.

Hryniuk W, Ragaz J, Peters W.

J Clin Oncol. 2004 Feb 15;22(4):750-1; author reply 751-3. No abstract available.

PMID:
14966105
[PubMed - indexed for MEDLINE]
Free Article
15.

Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: potential for intervention with 17-allylamino geldanamycin.

Nielsen TO, Andrews HN, Cheang M, Kucab JE, Hsu FD, Ragaz J, Gilks CB, Makretsov N, Bajdik CD, Brookes C, Neckers LM, Evdokimova V, Huntsman DG, Dunn SE.

Cancer Res. 2004 Jan 1;64(1):286-91.

PMID:
14729636
[PubMed - indexed for MEDLINE]
Free Article
16.

Increased use of adjuvant regional radiotherapy for node-positive breast cancer in British Columbia.

Chua B, Olivotto IA, Weir L, Kwan W, Truong P, Ragaz J.

Breast J. 2004 Jan-Feb;10(1):38-44.

PMID:
14717758
[PubMed - indexed for MEDLINE]
17.

EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer.

Hughes-Davies L, Huntsman D, Ruas M, Fuks F, Bye J, Chin SF, Milner J, Brown LA, Hsu F, Gilks B, Nielsen T, Schulzer M, Chia S, Ragaz J, Cahn A, Linger L, Ozdag H, Cattaneo E, Jordanova ES, Schuuring E, Yu DS, Venkitaraman A, Ponder B, Doherty A, Aparicio S, Bentley D, Theillet C, Ponting CP, Caldas C, Kouzarides T.

Cell. 2003 Nov 26;115(5):523-35.

PMID:
14651845
[PubMed - indexed for MEDLINE]
Free Article
18.

Benefit of Paclitaxel in estrogen receptor-negative versus estrogen receptor-positive early breast cancer.

Bryce C, Kennecke H, Chia S, Ragaz J.

J Clin Oncol. 2003 Dec 1;21(23):4465; author reply 4465-6. No abstract available.

PMID:
14645445
[PubMed - indexed for MEDLINE]
Free Article
19.

Long-term survival of patients with supraclavicular metastases at diagnosis of breast cancer.

Olivotto IA, Chua B, Allan SJ, Speers CH, Chia S, Ragaz J.

J Clin Oncol. 2003 Mar 1;21(5):851-4. Epub 2003 Mar 1.

PMID:
12610184
[PubMed - indexed for MEDLINE]
Free Article
20.

Adjuvant trials of aromatase inhibitors: determining the future landscape of adjuvant endocrine therapy.

Ragaz J.

J Steroid Biochem Mol Biol. 2001 Dec;79(1-5):133-41. Review.

PMID:
11850217
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk